ROCKWELL MEDICAL, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $69.3M | $101.5M | $83.6M | $72.8M | $61.9M |
| Gross profit | $11.7M | $17.5M | $8.7M | $4.1M | -$2.4M |
| Operating income | -$4.7M | $608,000 | -$6.7M | -$16.8M | -$30.3M |
| Cost of revenue | $57.6M | $84.0M | $74.9M | $68.7M | $64.4M |
| Cash from operations | -$659,000 | $4.2M | -$9.4M | -$16.9M | -$33.5M |
| Capital expenditure | $542,000 | $1.0M | $284,000 | — | — |
| Free cash flow | -$1.2M | $3.2M | -$9.7M | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $57.1M | $59.2M | $52.2M | $46.6M | $48.6M |
| Total liabilities | $20.2M | $26.6M | $30.9M | $32.5M | $46.0M |
Shares outstanding 39.5M · Free float 76.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.